The presence of promatrix metalloproteinase-3 and its relation with different categories of coal workers' pneumoconiosis

Mediators of Inflammation

Volumn 13, Issue 2, 2004, Pages 105-109

  Altin, Remzi ^a   Kart, Levent ^a   Tekin, Ishak ^a   Armutcu, Ferah ^a   Tor, Meltem ^a   Örnek, Tacettin ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Coal miners; Matrix metalloproteinases; Pneumoconiosis; Promatrix metalloproteinase 3

Indexed keywords

ENZYME PRECURSOR; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COAL WORKER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; OCCUPATIONAL EXPOSURE; PNEUMOCONIOSIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADULT; COAL MINING; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PNEUMOCONIOSIS; PROTEIN PRECURSORS; SMOKING; STATISTICS;

EID: 2542547347     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350410001688549     Document Type: Article

References (25)

1. Birkedal-Hansen HW, Moore GI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Oral Biol Med 1993; 4: 197-250.
2. Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732: 11-21.
3. Gómez D, Alonso D, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111-122.
4. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am Rev Respir Cell Mol Biol 1999; 20: 1100-1102.
5. Greenwald RA, Zucker S, Golub LM. Inhibition of matrix metalloproteinases: therapeutic implications. Ann NY Acad Sci 1999; 878: 761.
6. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
7. Katrib A, Tak PP, Bertouch JV, et al. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology 2001; 40: 988-994.
8. Posthumus MD, Limburg PC, Westra J, Cats HA, Stewart RE, van Leeuwen MA, van Rijswijk MH. Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Rheumatology 1999; 38: 1081-1087.
9. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology 2002; 41: 78-87.
10. Arnaud C, Valérie LC, Frédérique N, et al. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheumatism 2002; 46: 1754-1762.
11. Allan J, Hembry R, Angal S, Reynolds J, Murphy G. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci 1991; 99: 789-795.
12. Suzuki K, Kan C, Hung W, Gehring M, Brew K, Nagase H. Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1). Biol Chem 1998; 379: 185-191.
13. Lynn TT. Coal workers' lung disease and silicosis. In: Alfred PF, ed. Fishman's Manual of Pulmonary Diseases and Disorders, 3rd edn, McGraw-Hill, 2002: 238-249.
14. Rom WN. Basic mechanisms leading to focal emphysema in coal worker's pneumoconiosis. Environ Res 1990; 53: 16-28.
15. International Labour Office (ILO). Guidelines for the use of ILO international classification of radiographs of pneumoconioses. Occupational Safety and Health Series, No. 48. Geneva: ILO, 1980.
16. Kuhn DC, Stauffer JL, Gaydos LJ, Demers LM. Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners. J Toxicol Environ Health 1995; 46: 9-21.
17. Brown GM, Brown DM, Donaldson K. Persistent inflammation and impaired chemotaxis of alveolar macrophages on cessation of dust exposure. Environ Health Perspect 1992; 97: 91-94.
18. Vaillant P, Menard O, Vignaud JM, Martinet N, Martinet Y. The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 1996; 51: 145-152.
19. Porcher JM, Lafuma C, el Nabout R, et al. Biological markers as indicators of exposure and pneumoconiotic risk: prospective study. Int Arch Occup Environ Health 1993; 65: 209-213.
20. Soleilhac JM, Lafuma C, Porcher JM, Auburtin G, Roques BP. Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: enhancement of its activity in serum of underground miners exposed to coal dust particles. Eur J Clin Invest 1996; 26: 1011-1017.
21. Manicourt DH, Fujimoto N, Obata K, Thonar EJ. Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 1994; 37: 1774-1783.
22. Ashcroft GS, Horan MA, Herrick SE, Tarnuzzer RW, Schultz GS, Ferguson MW. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res 1997; 290: 581-591.
23. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci 1999; 40: 2676-2682.
24. Yin L, Morita A, Tsuji T. Alterations of extracellular matrix induced by tobacco smoke extract. Arch Dermatol Res 2000; 292: 188-194.
25. Liu PY, Chen JH, Li YH, Wu HL, Shi GY. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost 2003; 90: 132-139.